Table 2.

Best response pre-RECIST V.1.1/post-RECIST V.1.1-defined progression

	Best response after RECIST V.1.1 progression	Best response prior to RECIST V.1.1 progression
		CR	PR	SD	PD	Total
n=116 patients with response post-RECIST V.1.1 progression and no further PD events	iCR	6	13	0	5	24 (20.7%)
	iPR	1	40	6	10	57 (49.1%)
	iSD	0	2	12	21	35 (30.2%)
	Total	7 (6.0%)	55 (47.4%)	18 (15.5%)	36 (31.0%)	116
n=116 patients with response post-RECIST V.1.1 progression followed by progression/death	iPR		25	5	22	52 (44.8%)
	iSD		3	23	38	64 (55.2%)
	Total		28 (24.1%)	28 (24.1%)	60 (51.7%)	116

The bold values identify the 138 responders with iSD or better post-RECIST V.1.1 PD whose duration of response are summarized in online supplementary figure 1.

iCR/CR, complete response; iPR/PR, partial response; iSD/SD, stable disease; PD, progression of disease; RECIST, Response Evaluation Criteria in Solid Tumours.